To,
The Members,
Adline Chem Lab Limited
Your Directors have pleasure in presenting their 37th Annual Report on
the business and operations of the Company and the Audited Accounts for the Financial Year
ended 31st March, 2025.
1. Financial Summary/Highlights of Performance of The Company
(Rs. In Lakhs)
Particulars |
Year ended March 2025 |
Year ended March 2024 |
I. Total Revenue |
24.89 |
0.01 |
II. Total Expenditure |
45.46 |
30.29 |
III. Profit/(Loss) Before Exceptional Item and Tax (I-II) |
(20.57) |
(30.28) |
IV. Profit (Loss) after exceptional items and before tax |
(20.57) |
(30.28) |
V. Provision for Taxation |
(8.44) |
(3.10) |
VI. Profit/(Loss) After Tax |
(12.13) |
(27.18) |
2. Performance and State of Affairs of the Company:
During the year under review, the Company has incurred loss of Rs. 12.13 (Rs. In Lakhs)
the Board of Directors of the Company is continuously making efforts for the growth of the
Company.
3. Change In Nature Of Business:
There has been no change in the business of the Company during the financial year ended
31st March, 2025.
4. Dividend:
The Company has not declared any dividend during the year.
5. Transfer To Reserve
Company has negative reserves of Rs. 788.50/- (Rs. In Lakhs) as compared to previous
year i.e., negative Rs. 776.38/-(Rs. In Lakhs).
6. Share capital:
The Paid up share capital of the Company as on 31st March, 2025 was
Rs.5,85,00,000/- consisting of 58,50,000 Equity Shares of Rs. 10 each fully paid up as on
31st March, 2025, the Company has not issued any shares with differential
voting rights nor granted stock options nor do sweat equity and none of the Directors of
the Company hold any convertible instruments.
7. Material changes and Commitments, if any, affecting the Financial Position of
the Company which have occurred between the End of the Financial Year of the Company to
which the financial statements relate and the Date of the Report:
There have been no material changes and commitments affecting the financial position of
the Company which have occurred between the end of the Financial Year of the Company to
which the financial statements relate and the date of the Report.
8. Performance and financial position of each of the subsidiaries, associates,
and joint venture Companies:
As on 31st March, 2025, Company doesn't have any Subsidiary, Associates and
Joint Venture Companies at the end of the year.
9. Deposits:
The Company has neither accepted nor renewed any deposit within the meaning of the
Companies (Acceptance of Deposits) Rules, 2014 during the year under review. However, loan
from directors/ Relative of Directors taken during the year are as follows:
Name of Director |
Loan taken during the year |
Loan remaining at the end of the year |
Mr. Hemant Parikh |
32,00,000 |
35,63,215 |
Mrs. Tarla Parikh |
1,11,111 |
1,20,679 |
10. Disclosure regarding issue of Employee Stock Option:
Company has not issued any Employee Stock Option during the year.
11. Annual Return on website:
The Company is having website i.e. www.adlinechem.com and Annual Return of Company has
been published on such website. Link of the same is given below: www.adlinechem.com
12. Disclosure regarding issue of Sweat Equity shares:
During the year, the Company has not issued Sweat Equity shares. Hence, details as per
Rule 8(13) of the Companies (Share Capital and Debentures) Rule, 2014 are not reported
yet.
13. Corporate Social Responsibility (CSR)
Corporate Social Responsibility (CSR) is not applicable to the Company during the year.
14. Directors:
A. Details of Appointment/resignation of Directors and Key Managerial Personnel:
Details of the Directors of the company as on 31.03.2025 are as follows:
Sr. No. Name of the Director |
DIN |
Designation |
1. Shivani Pathak |
10481354 |
Director |
2. Hemant Amrish Parikh |
00027820 |
Director |
3. Dhawal Akhilesh Deopura |
09509762 |
Director |
Changes in Directorship during the year:
Name of Director |
DIN |
Nature of change |
Designation |
Date |
Dhawal Akhilesh Deopura |
09509762 |
Appointment |
Additional Director |
11/12/2024 |
Chintan Umeshbhai Bhatt |
09289 074 |
Appointment |
Additional Director |
13/11/2024 |
Chintan Umeshbhai Bhatt |
09289074 |
Cessation |
Additional Director |
21/11/2024 |
Digesh Mansukhlal |
09218553 |
Cessation |
Additional Director |
23/08/2024 |
Deshaval Hemant Amrish Parikh |
00027820 |
Change in Designation |
Director |
27/09/2024 |
Shivani Pathak |
10481354 |
Change in Designation |
Director |
27/09/2024 |
Dhawal Akhilesh Deopura |
09509762 |
Change in Designation |
Director |
16/01/2025 |
Details of the Key Managerial Personnel of the Company as on 31.03.2025
are as follows:
Sr. No. Name of the Director |
DIN/PAN |
Designation |
1. Sarang Bharatbhai Pathak |
02663344 |
Managing Director |
2. Kuldip Ashokkumar Parekh |
BFDPP4709J |
CFO |
B. Statement on declaration given by independent directors under Section 149(6) Of the
Act:
The Company has received necessary declarations from all Independent Directors of the
Company in accordance with the provisions of Section 149(7) of the Companies Act, 2013
confirming that they meet the criteria of independence as prescribed under Section 149(6)
of the Companies Act, 2013.
C. Statement with regards to integrity, expertise and experience of independent
directors:
Your Directors are of the opinion that the Independent Directors of the Company are of
high integrity and suitable expertise as well as experience (including proficiency).
D. Formal Annual Evaluation
The Board of Directors has carried out an annual evaluation of its own performance,
Board committees, and individual directors pursuant to the provisions of the Act and SEBI
Listing Regulations.
The performance of the Board was evaluated by the Board after seeking inputs from all
the directors on the basis of criteria such as the board composition and structure,
effectiveness of board processes, information and functioning, etc. The performance of the
committees was evaluated by the Board after seeking inputs from the committee members on
the basis of criteria such as the composition of committees, effectiveness of committee
meetings, etc.
The above criteria are broadly based on the Guidance Note on Board Evaluation issued by
the Securities and Exchange Board of India on January 5, 2017. In a separate meeting of
independent directors, performance of non-independent Directors, the Board as a whole and
Chairman of the Company was evaluated, taking into account the views of executive
directors and non-executive directors.
Performance evaluation of independent directors was done by the entire Board, excluding
the independent director being evaluated.
E. Policy on Director's Appointment and Remuneration
The Company has a Nomination and Remuneration Committee. The Committee reviews and
recommend to the Board of Directors about remuneration for Directors and Key Managerial
Personnel and other employee up to one level below of Key Managerial Personnel. The
Company does not pay any remuneration to the Non-Executive Directors of the Company other
than sitting fee for attending the Meetings of the Board of Directors and Committees of
the Board.
The Company has devised the Nomination and Remuneration Policy for the appointment,
reappointment and remuneration of Directors, Key Managerial Personnel and Senior
Management Personnel. All the appointment, re-appointment and remuneration of Directors,
Key Managerial Personnel and Senior Management Personnel are as per the Nomination and
Remuneration Policy of the company.
15. Conservation of energy, technology absorption and foreign exchange earnings and
outgo:
The details of conservation of energy, technology absorption, foreign exchange earnings
and outgo are attached herewith as Annexure-A.
16. Meetings:
A calendar of Meetings is prepared and circulated in advance to the Directors. During
this year, 6 (Six)meetings of the Board of Directors were held i.e., 23rd May,
2024,15th July, 2024, 24th August, 2024, 13th November,
2024, 11th December, 2024, 04th February, 2025.
The intervening gap between the Meetings was within the period prescribed under The Act
and The Securities Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015[LODR].
17. Details of establishment of vigil mechanism for directors and employees:
The Company has established a vigil mechanism and accordingly framed a Whistle Blower
Policy. The policy enables the employees to report to the management instances of
unethical behaviour, actual or suspected fraud or violation of Company's Code of Conduct.
Further the mechanism adopted by the Company encourages the Whistle Blower to report
genuine concerns or grievances and provide for adequate safe guards against victimization
of Whistle Blower who avails of such mechanism and also provides for direct access to the
Chairman of the Audit Committee, in exceptional cases.
The functioning of vigil mechanism is reviewed by the Audit Committee from time to
time. None of the Whistle blowers has been denied access to the Audit Committee of the
Board. The Whistle Blower Policy of the Company is available on the website of the Company
www.adlinechem.com.
18. Particulars of loans given, guarantees given, investments made and securities
provided:
Details of Loans, Guarantees and Investments covered under the provisions of Section
186 of the Companies Act, 2013 are given in the Notes to the Financial Statements.
19. Managerial Remuneration
The information required pursuant to Section 197(12) of The Companies Act, 2013 read
with Rule 5(1),5(2) and 5(3) of The Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 in respect of employees of the Company is enclosed as Annexure-B
which forms part of this report.
Further, there were no employee getting salary in excess of the limit as specified
under the provisions of Section 197 (12) of the Companies Act, 2013 read with rule 5(2)
and 5(3) of the Companies (Appointmentand Remuneration of Managerial Personnel) Rules,
2014.
The Nomination & Remuneration Policy are available on the Company's website:
www.adlinechem.com.
20. Particulars of contracts or arrangements with related parties
During the period under review, the Company has not entered into any
contracts/arrangement/ transaction with related parties which is required to be reported
in Form No. AOC-2 in terms of Section 188 of the Companies Act, 2013 and Rule 8A of the
Companies(Accounts) Rules, 2014. Hence, disclosure as required in Form AOC-2 is not
attached with this report. Disclosures under Para A of Schedule V of Listing Regulations
enclosed herewith as Annexure-C.
21. Auditors:
Statutory Auditors:
At the 34thAnnual General Meeting (AGM) held on 16th September,
2022, the present Auditors of the Company M/s. Deepak Soni& Associates, Chartered
Accountants, Ahmedabad, were appointed as Statutory Auditors of the Company for a period
of 5 years i.e. for financial years 2022-23 to 2026-2027. They continue to hold office as
Statutory Auditors till the conclusion of 39thAGM to be held in the year 2027.
Further, M/s. Deepak Soni& Associates resigned as Statutory Auditor of the Company
w.e.f 2nd August, 2024 due to Unavoidable Circumstances.
Further, to fill the Casual Vacancy caused by the resignation of M/s. Deepak Soni&
Associates hereby accorded to appoint, Jain Kedia and Sharma Chartered Accountants,
Ahmedabad were appointed as Statutory Auditors of the Companyfor F.Y 2024-2025 and for a
period of 5 years i.e. for financial years 2024-25 to 2028-2029.
Auditors' Report:
The Statutory Auditor's Report on the financial statement for the FY 2024-25 contains
emphasis of matter which is self-explanatory. The remarks of the Auditors are
self-explanatory and have been explained in Notes on Accounts.
Secretarial Auditors:
The Board of Directors in their meeting held on 6th June, 2025 has approved
the appointment of M/s. lshit Vyas & Co., Practicing Company Secretaries, as a
Scrutinizer for the purpose of 37th Annual General Meeting (AGM) and also
approved the appointment of M/s. lshit Vyas &Co., Practicing Company
Secretaries, Ahmedabad as the Secretarial Auditors of the Company for the period of five
consecutive financial years that is from the conclusion of ensuing 37th Annual
General Meeting of the Company until the conclusion of 42nd Annual General
Meeting to carry out the secretarial audit from the financial year 2025-26 till 2029-30.
The Secretarial Audit Report for the financial year 2024-25, in Form MR-3 provided by
M/s Jitendra Parmar & Associates, Practicing Company Secretary (Firm Registration No.
S2023GJ903900, Membership No. F11336, COP No. 15863) does not contain any qualification,
reservation or adverse remark except mentioned below and is annexed to this report as
"Annexure-D".
During the financial year 2024-2025, no fraud was reported by the Secretarial Auditors
of the Company in their Audit Report.
22. Management Discussion and Analysis Report
A report on Management Discussion and Analysis, as required in terms of Regulation
34(2) of LODR forms part of this Report. It deals with the Business Operations and
Financial Performance, Research & Development Expansion & Diversification, Risk
Management, Marketing Strategy, Safety & Environment, Human Resource Development, etc.
enclosed as per Annexure-E.
23. Corporate Governance Report:
As per Regulation 15(2) of the SEBI Listing Regulations, compliance with the corporate
governance provisions as specified in regulation 17 to 27 and clauses (b) to (i) of
sub-regulation (2) of regulation 46 and para-C, D and E of Schedule V, shall not apply in
respect of the listed entity having paid up equity share capital not exceeding rupees ten
crore and net worth not exceeding rupees twenty five crore, as on the last day of the
previous financial year. At present, the Company is not required to comply with Corporate
Governance regulations as none of the above referred limits have been triggered. The
details of the same is enclosed as Annexure-F.
24. Risk management:
The Company is aware of the risks associated with the business. It regularly analyses
and takes corrective actions for managing/mitigating the same.
The Company has framed a formal Risk Management Framework for risk assessment and risk
minimization which is periodically reviewed to ensure smooth operation and effective
management control. The Audit Committee also reviews the adequacy of the risk management
framework of the Company, the key risks associated with the business and measure and steps
in place to minimize the same.
25. Directors' Responsibility Statement:
As stipulated in Section 134(3)(c) read with sub section 5 of the Companies Act, 2013,
Directors subscribe to the "Directors' Responsibility Statement", and confirm
that:
a. In preparation of annual accounts for the year ended 31stMarch, 2025, the
applicable accounting standards have been followed and that no material departures have
been made from the same;
b. The Directors had selected such accounting policies and applied them consistently
and made judgments and estimates that are reasonable and prudent so as to give a true and
fair view of the state of affairs of the Company at the end of the financial year and of
the profit or loss of the Company for that year;
c. The Directors had taken proper and sufficient care for the maintenance of adequate
accounting records in accordance with the provisions of the Companies Act, 2013, for
safeguarding the assets of the Company and for preventing and detecting fraud and other
irregularities;
d. The Directors had prepared the annual accounts for the year ended 31stMarch,
2025 on going concern basis.
e. The Directors had laid down the internal financial controls to be followed by the
Company and that such Internal Financial Controls are adequate and were operating
effectively; and
f. The Directors had devised proper systems to ensure compliance with the provisions of
all applicable laws and that such systems were adequate and operating effectively.
26. Disclosure under the Sexual Harassment of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013:
The Company has constituted Internal Complaints Committee under the Sexual Harassment
of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the company
has complied with provisions of the same.
There were no incidences of sexual harassment reported during the year under review, in
terms of the provisions of the Sexual Harassment of Women at Workplace (Prevention,
Prohibition and Redressal) Act, 2013.
27. Directors Training & Familiarization:
The Directors are regularly informed during the meetings of the Board and the
Committees, of the activities of the Company, its operations and issues faced by the
Engineering Industry. Considering the long association of the Directors with the Company
and their seniority and expertise in their respective areas of specialization and
knowledge of the engineering industry, their training and familiarization were conducted
in the below mentioned areas:
The Roles, Rights, Responsibilities and Duties of Independent Directors
Business Development Strategy and Plans
Changes brought in by the introduction of the Securities Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015
Changes in the Securities Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015
28. Audit Committee:
The Audit Committee of the Board consists of Two Independent and One Non-Executive
Non-Independent Director. The composition, role, terms of reference as well as power of
the Audit Committee are in accordance with the provisions of Regulation 18 of LODR and
Section 177 of The Act and Rules framed thereunder.
The details of all related party transactions are placed periodically before the Audit
Committee. All the recommendations made by the Audit Committee were accepted by the Board.
The Company has in place a Vigil Mechanism; details of which are available on the
Company's website.
The Audit Committee comprises of the following Members as on 31st March,
2025:-
Name |
Designation |
Category |
Mr. Dhawal Akhilesh Deopura |
Chairman |
Non-Executive, Independent Director |
Mr. Digesh Deshaval |
Chairman (Resigned w.e.f. 23/08/2024) |
Non-Executive, Independent Director |
Ms. Shivani Pathak |
Member |
Non-Executive, Independent Director |
Mr. Parikh H. A. |
Member |
Non- Executive, Non- Independent |
There were 6 (Six) Meetings of the Audit Committee of the Board of Directors held
during the Financial Year 2024-2025, (i.e., 23thMay, 2024, 15thJuly,
2024, 24th August, 2024, 13th November, 2024, 11th
December, 2024 and 04th February, 2025).
The Statutory Auditors and Chief Financial Officer attend the Audit Committee Meetings
as Invitees. The Company Secretary and Compliance Officer acts as Secretary to the Audit
Committee. The Audit Committee has made observations and recommendations to the Board of
Directors, which have been noted and accepted by the Board.
During the Financial Year 2024-2025, all recommendations made by the Audit Committee to
the Board of Directors were accepted by the Board and there were no instances where the
recommendations were not accepted.
29. Nomination and Remuneration Committee:
In compliance with Section 178 of The Act, Your Company has in place a "Nomination
and Remuneration Committee". The powers, role and terms of reference of the
Nomination and Remuneration Committee cover the areas as contemplated under Regulation 19
of LODR and Section 178 of The Act, and Rules and Regulations, framed thereunder, besides
other terms as may be referred by the Board of Directors.
The Nomination and Remuneration Committee comprises of the following Members as on
March 31st, 2025:-
Name |
Designation |
Category |
Mr. Digesh Deshaval |
Member (Resigned w.e.f. 23/08/2024) |
Non-Executive, Independent Director |
Mr. Dhawal Akhilesh Deopura |
Member |
Non-Executive, Independent Director |
Ms. Shivani Pathak |
Chairman |
Non-Executive, Independent Director |
Mr. Parikh H. A. |
Member |
Non- Executive, Non- Independent |
There was 4 (Four) Meetings of the Nomination and Remuneration Committee of the Board
of Directors held during the Financial Year 2024-25 i.e., on 15th July, 2024,
24thAugust, 2024, 13th November, 2024, 11th December,
2024.
30. Stakeholders' Relationship Committee:
Pursuant to the provisions of Section 178 of the Companies Act, 2013, your Company has
constituted a Stakeholders' Relationship Committee of the Board of Directors, comprising
of the following Members during the Financial Year 2024-2025:-
Name |
Designation |
Category |
Mr. Digesh Deshaval |
Chairman (Resigned w.e.f. 23/08/2024) |
Non-Executive, Independent Director |
Mr. Dhawal Akhilesh Deopura |
Chairman |
Non-Executive, Independent Director |
Ms. Shivani Pathak |
Member |
Non-Executive, Independent Director |
Mr. Parikh H. A. |
Member |
Non- Executive, Non- Independent |
During the Financial Year 2024-25, 1 (One) Meeting of the Stakeholders' Relationship
Committee was held, i.e., on 11th December, 2024.
31. Independent Director Committee
Name |
Designation |
Category |
Mr. Digesh Deshaval |
Chairman (Resigned w.e.f. 23/08/2024) |
Non-Executive, Independent Director |
Mr. Dhawal Akhilesh Deopura |
Chairman |
Non-Executive, Independent Director |
Ms. Shivani Pathak |
Member |
Non-Executive, Independent Director |
During the Financial Year 2024-25, 2 (two) Meeting of the Independent Director
Committee was held, i.e., on 13th November, 2024 and 11th December,
2024.
32. Secretarial Standards
Secretarial Standards for the Board of Directors and General Meetings (SS-1 & SS-2)
are applicable to the Company. The Company has complied with the provisions of both
Secretarial Standards.
33. Maintenance of cost records:
The Company is not require to maintain cost records as specified by the Central
Government under subsection (1) of section 148 of the Companies Act, 2013, and accordingly
such accounts and records are not made and maintained.
34. No application/ proceeding under IBC:
Neither any application is made, nor any proceeding is pending under the Insolvency and
Bankruptcy Code, 2016 (IBC) during the year under review and accordingly the Company has
no information to offer in this regard.
35. Difference in valuation:
The company has never made any one-time settlement against the loans obtained from
Banks and Financial Institution and hence this clause is not applicable.
36. Acknowledgements:
Your Directors wish to place on record sincere appreciation for the support and
co-operation received from various Central and State Government Departments, organizations
and agencies. Your Directors also gratefully acknowledge all stakeholders of your Company,
viz., Shareholders, customers, dealers, vendors, banks and other business partners for
excellent support received from them during the Financial Year under review. Your
Directors also express their warm appreciation to all the employees of the Company for
their unstinted commitment and continued contribution to the growth of your Company.
Date: 13.06.2025 |
By order of the Board, |
Place: Ahmedabad |
For, Adline Chem Lab Limited |
SD/- |
SD/- |
Managing Director |
Director |
Pathak S. B. |
Parikh H. A. |
DIN: 02663344 |
DIN: 00027820 |